Bicocca Open Archive

Logo unimib boa
PUOTI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.889
AS - Asia 13.768
EU - Europa 8.246
SA - Sud America 2.233
AF - Africa 326
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 7
Totale 39.482
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.631
SG - Singapore 5.116
IT - Italia 2.587
VN - Vietnam 2.410
HK - Hong Kong 2.182
CN - Cina 1.909
RU - Federazione Russa 1.753
BR - Brasile 1.714
CA - Canada 1.051
SE - Svezia 782
IE - Irlanda 778
DE - Germania 711
BD - Bangladesh 484
FR - Francia 389
IN - India 312
GB - Regno Unito 292
ID - Indonesia 231
AT - Austria 205
AR - Argentina 194
KR - Corea 185
FI - Finlandia 176
IQ - Iraq 154
UA - Ucraina 137
NL - Olanda 132
TR - Turchia 128
MX - Messico 119
EC - Ecuador 102
PK - Pakistan 97
ZA - Sudafrica 93
JP - Giappone 80
ES - Italia 75
SA - Arabia Saudita 71
PH - Filippine 66
CO - Colombia 54
UZ - Uzbekistan 54
PL - Polonia 51
VE - Venezuela 43
PY - Paraguay 37
MY - Malesia 35
MA - Marocco 34
TN - Tunisia 32
KE - Kenya 31
EG - Egitto 30
ET - Etiopia 28
CL - Cile 25
AE - Emirati Arabi Uniti 24
JO - Giordania 24
PE - Perù 24
CZ - Repubblica Ceca 22
OM - Oman 22
JM - Giamaica 20
NP - Nepal 20
CR - Costa Rica 19
IL - Israele 19
UY - Uruguay 19
DZ - Algeria 18
BO - Bolivia 17
IR - Iran 17
LB - Libano 17
CH - Svizzera 16
KZ - Kazakistan 16
BE - Belgio 15
LT - Lituania 15
AZ - Azerbaigian 13
TH - Thailandia 13
GR - Grecia 12
BG - Bulgaria 11
DK - Danimarca 11
DO - Repubblica Dominicana 11
KG - Kirghizistan 11
PT - Portogallo 11
AL - Albania 10
PS - Palestinian Territory 10
AU - Australia 9
HU - Ungheria 9
HN - Honduras 8
NG - Nigeria 8
PA - Panama 8
SN - Senegal 8
BH - Bahrain 7
BY - Bielorussia 7
KW - Kuwait 7
RO - Romania 7
TW - Taiwan 7
CI - Costa d'Avorio 6
GH - Ghana 6
MU - Mauritius 6
MD - Moldavia 5
NI - Nicaragua 5
TT - Trinidad e Tobago 5
AO - Angola 4
CY - Cipro 4
EE - Estonia 4
HR - Croazia 4
KH - Cambogia 4
LY - Libia 4
NZ - Nuova Zelanda 4
SI - Slovenia 4
SY - Repubblica araba siriana 4
A2 - ???statistics.table.value.countryCode.A2??? 3
Totale 39.414
Salva come PNG Salva come JPEG
Città #
Singapore 2.905
Hong Kong 2.158
San Jose 1.225
Ashburn 1.176
Ann Arbor 1.097
Toronto 900
Dublin 769
Ho Chi Minh City 741
Milan 725
Hanoi 594
Fairfield 593
New York 571
Chandler 479
Chicago 439
Houston 424
Frankfurt am Main 420
The Dalles 399
Hefei 393
Santa Clara 388
Woodbridge 386
Princeton 382
Dallas 379
Los Angeles 365
Wilmington 295
Rome 250
Lauterbourg 247
Seattle 232
Beijing 226
Cambridge 197
Altamura 193
Lawrence 187
Council Bluffs 186
Buffalo 183
Seoul 176
Moscow 167
Jakarta 160
São Paulo 148
Jacksonville 117
Nuremberg 117
Vienna 113
San Diego 111
Dearborn 103
Shanghai 84
Helsinki 83
Haiphong 80
Da Nang 77
Tokyo 69
London 65
Orem 65
Andover 64
Baghdad 61
Boardman 61
Salt Lake City 52
Tashkent 52
Turin 50
Munich 49
Rio de Janeiro 47
Biên Hòa 45
Dong Ket 45
Brooklyn 44
Naples 44
Lappeenranta 42
Nanjing 42
Atlanta 41
Guangzhou 41
Ha Long 41
Montreal 41
Denver 40
Figino 37
Tampa 37
Elk Grove Village 35
Hải Dương 35
Quito 35
Warsaw 35
Bologna 34
Phoenix 34
Chennai 33
Guayaquil 33
Johannesburg 33
Quận Bình Thạnh 33
Dhaka 32
Amsterdam 31
Falls Church 30
Lahore 30
Curitiba 29
Mumbai 29
Brasília 28
Lachine 28
New Delhi 28
Belo Horizonte 27
Hangzhou 27
Jeddah 27
Ninh Bình 27
Stockholm 27
Palermo 26
Columbus 25
Florence 25
Kent 24
Vũng Tàu 24
Washington 24
Totale 23.703
Salva come PNG Salva come JPEG
Nome #
Sexually Transmitted Hepatitis 476
Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV-positive persons 383
24-Hour Blood Pressure Monitoring Patterns in HIV-Positive Patients and its Relationship with Arterial Distensibility 371
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 329
Characteristics and Clinical Implications of Carbapenemase-Producing Klebsiella pneumoniae Colonization and Infection, Italy 324
Durability of different initial regimens in HIV-infected patients starting antiretroviral therapy with CD4+ counts <200 cells/mm3 and HIV-RNA >5 log10 copies/mL 305
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 294
Brief Report: New HIV Diagnoses in PrEP-Experienced and PrEP-Naive Persons in the ICONA Cohort 278
Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: Data from the ICONA cohort 278
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 277
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapy 272
Cerebral Infectious Opportunistic Lesions in a Patient with Acute Myeloid Leukaemia: The Challenge of Diagnosis and Clinical Management 259
Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: Results from the Icona Foundation study 259
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 255
Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients 255
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 250
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 247
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus 243
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic-Clinical Management of HIV-1 Infected Persons 241
Ombitasvir/paritaprevir/ritonavir and dasabuvir combination treatment in patients with HIV/HCV coinfection: Results of an Italian compassionate use program 240
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 240
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: A cohort study 237
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 237
Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study 234
Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis c coinfection: Data from the ICONA foundation cohort 228
Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy 227
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials 226
Multiple concomitanti infezioni opportunistiche e linfomi aggressivi in una persona con HIV/AIDS che non assumeva la terapia ant 223
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 221
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 218
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 217
Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy 215
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 215
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 214
Surge of Mpox cases in Lombardy region, Italy, October 2023 - January 2024 212
SARS-CoV-2 RNA in plasma samples of COVID-19 affected individuals: a cross-sectional proof-of-concept study 212
Sex differences in electrolyte imbalances caused by SARS-CoV-2: A cross-sectional study 211
24 HOUR ARTERIAL DISTENSIBILITY IS RELATED WITH ABPM NON-DIPPING PATTERN IN HIVPOSITIVE PATIENTS 210
Mild Course of SARS-CoV-2 Infection in a Liver Transplant Recipient Undergoing Plasma Exchange and Defibrotide for Acute Graft Rejection 206
24-hours arterial distensibility is related with ABPM non-dipping pattern in HIV-positive patients 204
Successful pre- and posttransplant sofosbuvir-based anti-hepatitis C virus treatment in persons living with human immunodeficiency virus infection 203
COVID-19 in liver transplant candidates: Pretransplant and post-transplant outcomes - An ELITA/ELTR multicentre cohort study 203
Evaluation of the prognostic value of impaired renal function on clinical progression in a large cohort of HIV-infected people seen for care in Italy 201
ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients 201
Predictors of COVID-19 Readmission Among Patients Previously Hospitalized for SARS-CoV-2 200
Challenges and opportunities for hepatitis B virus screening in people attending PrEP services: a retrospective prevalence study 200
Tixagevimab/Cilgavimab Pre-exposure Prophylaxis in Patients with Lymphoproliferative Disorders on BTKi 199
Italian consensus guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis [Prise en charge de l'infection par le virus de l'hépatite B chez les patients atteints de polyarthrite rhumatoïde: conférence de consensus italienne] 199
Vaccinations in patients with multiple sclerosis: A Delphi consensus statement 197
Risk of severe non AIDS events is increased among patients unable to increase their CD4 + T-cell counts >200+/μl despite effective HAART 197
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 196
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C 194
The impact of DAA-mediated HCV eradication on CD4+ and CD8+ T lymphocyte trajectories in HIV/HCV coinfected patients: Data from the ICONA Foundation Cohort 194
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013 193
HIV-positive to HIV-positive liver transplantation: To be continued 191
Long-term outcomes of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy and as switch strategy in virologically suppressed persons with HIV: data from the ICONA cohort 190
Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy 190
Factors Influencing Depression Endpoints Research (FINDER): Baseline results of Italian patients with depression 189
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects from the ICONA Italian Cohort of HIV-Infected Patients 188
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons 187
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 187
Effectiveness and Tolerability of Dual Antiviral Therapy in Immunosuppressed Patients with Protracted SARS-CoV-2 Infection 186
Evaluation of HIV transmission clusters among natives and foreigners living in Italy 186
Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy 185
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres 184
Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort 182
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 180
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 179
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 178
Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than Adults 178
Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration 177
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference 175
Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data 174
Is physician assessment of alcohol consumption useful in predicting risk of severe liver disease among people with HIV and HIV/HCV co-infection? 173
HEFFICON: HIV effectiveness Italian conference 172
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 171
Similar survival but higher and delayed hepatocellular carcinoma recurrence in HIV-positive compared to negative cirrhotics undergoing liver transplantation 171
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014 171
Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy: A multinational prospective cohort study 170
Sustained virological response with 16-week glecaprevir/pibrentasvir after failure to sofosbuvir/velpatasvir in post-transplant severe HCV recurrence in HIV 168
Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2011 168
Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients 167
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational multicentric study (DALBITA study) 165
Corrigendum to “Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV” [J Hepatol 68 (2018) 33–41](S0168827817322596)(10.1016/j.jhep.2017.08.019) 165
Single-center outbreak of Pneumocystis jirovecii pneumonia in heart transplant recipients 165
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 165
Human immunodeficiency virus continuum of care in 11 european union countries at the end of 2016 overall and by key population: Have we made progress? 164
Impact of treatment with direct-acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co-infected individuals 162
A territory-wide opportunistic, hospital-based HCV screening in the general population from northern Italy: The 1969–1989 birth-cohort 162
Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience 162
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort 160
Trends in all-cause mortality of hospitalized patients due to SARS-CoV-2 infection from a monocentric cohort in Milan (Lombardy, Italy) 160
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 158
Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: Results from a cross-sectional survey on 7,014 workers in healthcare 158
A case of chronic bacterial prostatitis due to Mycoplasma genitalium 157
Exposure to abacavir and biomarkers of cardiovascular disease in HIV-1-infected patients on suppressive antiretroviral therapy: A longitudinal study 157
Pre-ART HIV-1 DNA in CD4+ T cells correlates with baseline VIRO-immunological status and outcome in patients under first-line ART 157
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 157
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 155
Prophylaxis and treatment of hepatitis B in immunocompromised patients 155
Totale 20.921
Salva come PNG Salva come JPEG
Categoria #
all - tutte 152.407
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 152.407
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021167 0 0 0 0 0 0 0 0 0 0 0 167
2021/20221.849 73 108 269 174 85 120 44 273 125 101 89 388
2022/20232.627 467 752 231 174 113 433 24 140 165 24 71 33
2023/20242.592 55 63 79 70 344 600 445 55 297 48 101 435
2024/20258.480 516 1.159 431 382 664 341 418 216 899 1.270 819 1.365
2025/202620.932 2.454 1.745 1.474 1.905 1.981 939 2.577 977 1.446 1.607 1.945 1.882
Totale 40.479